Shopping Cart 0
Cart Subtotal
AED 0

Windtree Therapeutics Inc (WINT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

Windtree Therapeutics Inc (Windtree Therapeutics), formerly Discovery Laboratories, Inc. is a specialty biotechnology company. It focuses on the development of novel KL4 surfactant therapies for patients with respiratory diseases and other potential applications. The company's lead development product Aerosurf (lucinactant for inhalation), is an investigational combination drug/device product for the treatment of respiratory distress syndrome (RDS) in premature infants. Its technology platforms comprise a novel proprietary KL4 surfactant, a synthetic, peptide-containing surfactant, which is structurally similar to pulmonary surfactant, and proprietary drug delivery technologies for the delivery of aerosolized KL4 surfactant and other inhaled therapies. Windtree Therapeutics is headquartered in Warrington, Pennsylvania, the US.

Windtree Therapeutics Inc (WINT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Windtree Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Windtree Therapeutics Enters into Agreement with Eleison Pharma 11

Discovery Labs Enters into Co-Development Agreement with Battelle Memorial Institute 12

Discovery Labs Amends Agreement with Battelle Memorial Institute 13

Licensing Agreements 15

Lee's Pharma Enters into Licensing Agreement with Windtree Therapeutics 15

Equity Offering 17

Windtree Therapeutics Raises USD2.6 Million in Private Placement of Shares 17

Windtree Therapeutics Raises USD10.5 Million in Private Placement of Units 19

Discovery Labs Raises USD40.2 Million in Public Offering of Units 21

Discovery Laboratories Completes Public Offering Of Shares For USD 50 Million 23

Discovery Labs Completes Public Offering Of Shares For USD 14.2 Million 24

Discovery Labs Announces Public Offering Of Shares For USD 25 Million 25

Discovery Labs Completes Public Offering Of Common Stock For USD 45 Million 26

Windtree Therapeutics Inc-Key Competitors 28

Windtree Therapeutics Inc-Key Employees 29

Windtree Therapeutics Inc-Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Recent Developments 31

Financial Announcements 31

Nov 14, 2017: Windtree Therapeutics Reports Third Quarter 2017 Financial Results 31

Aug 21, 2017: Windtree Therapeutics Reports Second Quarter 2017 Financial Results 33

May 15, 2017: Windtree Therapeutics Reports First Quarter 2017 Financial Results and Provides Key Business Updates 35

Mar 31, 2017: Windtree Therapeutics Reports Fourth Quarter 2016 Financial Results and Provides Key Business Updates 37

Clinical Trials 39

Jan 04, 2018: Windtree Therapeutics to Provide AEROSURF and Business Updates 39

Jun 29, 2017: Windtree Announces Top-Line Results from AEROSURF Phase 2b Clinical Trial for the Treatment of Respiratory Distress Syndrome in Premature Infants 40

Apr 11, 2017: Windtree Announces Successful Completion of Second and Final AEROSURF Phase 2b Clinical Trial Interim Safety Review 42

Feb 16, 2017: Windtree Therapeutics' Aerosolized KL4 Surfactant Reduces Lung Inflammation and Improves Survival in a High-Pathogen Avian Influenza Preclinical Study 43

Appendix 44

Methodology 44

About GlobalData 44

Contact Us 44

Disclaimer 44


List Of Figure

List of Figures

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Windtree Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Windtree Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Windtree Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Windtree Therapeutics Enters into Agreement with Eleison Pharma 11

Discovery Labs Enters into Co-Development Agreement with Battelle Memorial Institute 12

Discovery Labs Amends Agreement with Battelle Memorial Institute 13

Lee's Pharma Enters into Licensing Agreement with Windtree Therapeutics 15

Windtree Therapeutics Raises USD2.6 Million in Private Placement of Shares 17

Windtree Therapeutics Raises USD10.5 Million in Private Placement of Units 19

Discovery Labs Raises USD40.2 Million in Public Offering of Units 21

Discovery Laboratories Completes Public Offering Of Shares For USD 50 Million 23

Discovery Labs Completes Public Offering Of Shares For USD 14.2 Million 24

Discovery Labs Announces Public Offering Of Shares For USD 25 Million 25

Discovery Labs Completes Public Offering Of Common Stock For USD 45 Million 26

Windtree Therapeutics Inc, Key Competitors 28

Windtree Therapeutics Inc, Key Employees 29

Windtree Therapeutics Inc, Other Locations 30

Windtree Therapeutics Inc, Subsidiaries 30

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Windtree Therapeutics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Windtree Therapeutics Inc (Windtree Therapeutics), formerly Discovery Laboratories, Inc. is a specialty biotechnology company. It focuses on the development of novel KL4 surfactant therapies for patients with respiratory diseases and other potential applications. The company's lead development product Aerosurf (lucinactant for inhalation), is an investigational combination drug/device product for the treatment of respiratory distress syndrome (RDS) in premature infants. Its technology platforms comprise a novel proprietary KL4 surfactant, a synthetic, peptide-containing surfactant, which is structurally similar to pulmonary surfactant, and proprietary drug delivery technologies for the delivery of aerosolized KL4 surfactant and other inhaled therapies. Windtree Therapeutics is headquartered in Warrington, Pennsylvania, the US.

Windtree Therapeutics Inc (WINT)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Windtree Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Windtree Therapeutics Enters into Agreement with Eleison Pharma 11

Discovery Labs Enters into Co-Development Agreement with Battelle Memorial Institute 12

Discovery Labs Amends Agreement with Battelle Memorial Institute 13

Licensing Agreements 15

Lee's Pharma Enters into Licensing Agreement with Windtree Therapeutics 15

Equity Offering 17

Windtree Therapeutics Raises USD2.6 Million in Private Placement of Shares 17

Windtree Therapeutics Raises USD10.5 Million in Private Placement of Units 19

Discovery Labs Raises USD40.2 Million in Public Offering of Units 21

Discovery Laboratories Completes Public Offering Of Shares For USD 50 Million 23

Discovery Labs Completes Public Offering Of Shares For USD 14.2 Million 24

Discovery Labs Announces Public Offering Of Shares For USD 25 Million 25

Discovery Labs Completes Public Offering Of Common Stock For USD 45 Million 26

Windtree Therapeutics Inc-Key Competitors 28

Windtree Therapeutics Inc-Key Employees 29

Windtree Therapeutics Inc-Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Recent Developments 31

Financial Announcements 31

Nov 14, 2017: Windtree Therapeutics Reports Third Quarter 2017 Financial Results 31

Aug 21, 2017: Windtree Therapeutics Reports Second Quarter 2017 Financial Results 33

May 15, 2017: Windtree Therapeutics Reports First Quarter 2017 Financial Results and Provides Key Business Updates 35

Mar 31, 2017: Windtree Therapeutics Reports Fourth Quarter 2016 Financial Results and Provides Key Business Updates 37

Clinical Trials 39

Jan 04, 2018: Windtree Therapeutics to Provide AEROSURF and Business Updates 39

Jun 29, 2017: Windtree Announces Top-Line Results from AEROSURF Phase 2b Clinical Trial for the Treatment of Respiratory Distress Syndrome in Premature Infants 40

Apr 11, 2017: Windtree Announces Successful Completion of Second and Final AEROSURF Phase 2b Clinical Trial Interim Safety Review 42

Feb 16, 2017: Windtree Therapeutics' Aerosolized KL4 Surfactant Reduces Lung Inflammation and Improves Survival in a High-Pathogen Avian Influenza Preclinical Study 43

Appendix 44

Methodology 44

About GlobalData 44

Contact Us 44

Disclaimer 44


List Of Figure

List of Figures

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Windtree Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Windtree Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Windtree Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

Windtree Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Windtree Therapeutics Enters into Agreement with Eleison Pharma 11

Discovery Labs Enters into Co-Development Agreement with Battelle Memorial Institute 12

Discovery Labs Amends Agreement with Battelle Memorial Institute 13

Lee's Pharma Enters into Licensing Agreement with Windtree Therapeutics 15

Windtree Therapeutics Raises USD2.6 Million in Private Placement of Shares 17

Windtree Therapeutics Raises USD10.5 Million in Private Placement of Units 19

Discovery Labs Raises USD40.2 Million in Public Offering of Units 21

Discovery Laboratories Completes Public Offering Of Shares For USD 50 Million 23

Discovery Labs Completes Public Offering Of Shares For USD 14.2 Million 24

Discovery Labs Announces Public Offering Of Shares For USD 25 Million 25

Discovery Labs Completes Public Offering Of Common Stock For USD 45 Million 26

Windtree Therapeutics Inc, Key Competitors 28

Windtree Therapeutics Inc, Key Employees 29

Windtree Therapeutics Inc, Other Locations 30

Windtree Therapeutics Inc, Subsidiaries 30

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Windtree Therapeutics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.